MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    SCFAs participate in the pathogenesis of Parkinson’s disease by regulating NLRP3 inflammasomes activation

    Z. Mao, J. Xiong, Z. Min, Z. Xue (Wuhan, China)

    Objective: To explore the role and related mechanism of gut microbiota metabolites short-chain fatty acids(SCFAs) in the pathogenesis of Parkinson's disease(PD). Background: Growing research have…
  • 2022 International Congress

    Gait abnormalities relate to increased extracellular water in the substantia nigra in Parkinson’s disease patients

    M. Bange, G. Gonzalez-Escamilla, N. Lang, A. Radetz, H. Ding, D. Herz, W. Schöllhorn, M. Muthuraman, S. Groppa (Mainz, Germany)

    Objective: The aim of this study was to investigate the role of substantia nigra microstructural integrity in parkinsonian gait impairments. Background: Gait impairments are common…
  • 2022 International Congress

    Nicotine and influences on hyperkinetic movement disorders

    J. Qiu, L. Williams, H. Morales-Briceño, D. Olszewska, T. Lynch, V. Fung (Sydney, Australia)

    Objective: We describe hyperkinetic movement disorders with a variable response to smoking and nicotine and review clinical and pre-clinical evidence regarding the role of smoking,…
  • 2022 International Congress

    The Hidden Disease Burden and Treatment Experience of Patients with Essential Tremor: A Retrospective US Claims Analysis

    C. Vetterick, K. Lyons, R. Pendal, G. Belfort, B. Ravina (Boston, USA)

    Objective: To describe the attributes of patients with essential tremor (ET), associated comorbidities, and ET treatments using a US claims database. Background: ET is estimated…
  • 2022 International Congress

    Balance evaluation in Parkinson’s disease using a set of simple tests

    K. Krzysztoń, J. Stolarski, A. Poznańska, J. Kochanowski (Warsaw, Poland)

    Objective: The study aimed to evaluate balance using a proposed set of tests in people with Parkinson’s disease compared to healthy people. Background: Numerous balance…
  • 2022 International Congress

    Impulse control disorder following bilateral pallidothalamic tract focused ultrasound: a case report

    S. Farrand, P. Phal, K. Fernando, A. Evans, R. Blaze (Richmond, Australia)

    Objective: Description of a case of ICD following non-contemporaneous bilateral pallidothalamic focused ultrasound tractotomy. Background: Impulsive and compulsive behaviours in PD are hypothesized to largely…
  • 2022 International Congress

    Compound heterozygous PANK2 variants in two unrelated kindreds with atypical PKAN

    A. Saini, R. Mewara, B. Verma, V. Scaria, B. Bk, A. Srivastava, R. Rajan (New Delhi, India)

    Objective: To describe two unrelated individuals with progressive, late-onset Pantothenate kinase-associated neurodegeneration (PKAN) and a common missense variant in the PANK2 gene Background: Neurodegeneration with Brain-Iron Accumulation…
  • 2022 International Congress

    Changes in gait and mobility measures collected in daily living conditions, in different stages of Parkinson’s disease

    N. Geffen, K. Cohavi, N. Giladi, A. Thaler, R. Alcalay, J. Edgerton, J. Shirvan, J. Cedarbaum, J. Hausdorff, A. Mirelman (Tel Aviv, Israel)

    Objective: To explore mobility measures collected in daily-living conditions in different stages of PD. Background: Gait and mobility impairments are considered a cardinal sign in…
  • 2022 International Congress

    Clinicopathologic features of primary lateral sclerosis with TDP-43 presenting as atypical parkinsonism

    A. Murakami, S. Koga, S. Fujioka, K. Bieniek, H. Sekiya, M. Nakamura, Y. Tsuboi, M. Murray, Z. Wszolek, D. Dickson (Jacksonville, USA)

    Objective: To clarify clinicopathologic features of pathologically-confirmed primary lateral sclerosis (PLS). Background: PLS is a neurodegenerative disorder characterized by slowly progressive upper motor neuron signs…
  • 2022 International Congress

    Non-motor symptom characteristics in patients with essential tremor

    E. Jaakkola, E. Mäkinen, J. Joutsa, M. Eklund, S. Nuuttila, E. Honkanen, K. Lindholm, T. Noponen, T. Ihalainen, K. Murtomäki, T. Nojonen, R. Levo, T. Mertsalmi, F. Scheperjans, V. Kaasinen (Turku, Finland)

    Objective: The objective of this study was to evaluate non-motor symptoms in essential tremor (ET) and compare those to healthy controls (HCs). Background: ET is…
  • « Previous Page
  • 1
  • …
  • 113
  • 114
  • 115
  • 116
  • 117
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley